Dow Drops 438 Points on Losses for Amgen, Salesforce Shares

Dow Jones
Sep 08

DJ Dow Drops 438 Points On Losses For Amgen, Salesforce Shares

This article was automatically generated by MarketWatch using technology from Automated Insights.

The Dow Jones Industrial Average is declining Tuesday morning with shares of Amgen and Salesforce seeing the biggest declines for the blue-chip average.

Shares of Amgen (Amgen Inc.) and Salesforce (Salesforce Inc.) are contributing to the index's intraday decline, as the Dow (Dow Jones Industrial Average) was most recently trading 438 points, or 0.8%, lower.

Amgen's shares have declined $30.47, or 7.0%, while those of Salesforce have fallen $11.09, or 4.3%, combining for a roughly 247-point drag on the Dow.

Also contributing significantly to the decline are Johnson & Johnson (Johnson & Johnson), IBM (International Business Machines Corp.), and Microsoft (Microsoft Corp.).

A $1 move in any of the Dow's 30 components equates to a 5.94-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10